APP下载

丹红注射液联合卡托普利治疗慢性肺源性心脏病的效果评价

2021-12-02洪霞

智慧医学 2021年5期

洪霞

摘要:目的 评价慢性肺源性心脏病选择丹红注射液及卡托普利联合治疗方案的临床效果。方法 选取本院收治的慢性肺源性心脏病患者90例纳入研究。计算机随机法分组,两组均接受常规治疗,对照组单独加用卡托普利治疗,观察组在其基础上加用丹红注射液治疗,对比两组治疗效果差异。结果 观察组治疗总有效率高于对照组,治疗后心功能及肺功能各项指标均优于对照组(P〈0.05)。结论 慢性肺源性心脏病在常规用药同时联合应用丹红注射液及卡托普利治疗有助于提高临床治疗有效性,确切改善患者心肺功能,效果理想值得推广运用。

关键词:丹红注射液;卡托普利;慢性肺源性心脏病

[Abstract] Objective To evaluate the clinical effect of Danhong injection and captopril in the treatment of chronic pulmonary heart disease. Methods 90 patients with chronic pulmonary heart disease in our hospital were included in the study. The two groups were divided into two groups by computer random method. The control group was treated with captopril alone,and the observation group was treated with Danhong injection. The therapeutic effects of the two groups were compared. Results the total effective rate of the observation group was higher than that of the control group,and the indexes of cardiac function and pulmonary function were better than those of the control group(P0.05). Conclusion the combination of Danhong injection and captopril in the treatment of chronic pulmonary heart disease is helpful to improve the effectiveness of clinical treatment and improve the cardiopulmonary function of patients. The effect is ideal and worthy of popularization.

[Key words] Danhong injection;Captopril;Chronic pulmonary heart disease

肺組织结构和功能因肺动脉血管、胸廓和肺组织等慢性疾病影响导致肺血管压力及肺动脉压提升,导致右心室增大肥厚,发生伴或是不伴右心衰竭的心脏病被称之为慢性肺源性心脏病【1】。此类患者临床中多使用西医药物保守治疗,主要目的为抗感染,改善心力衰竭并纠正机体缺氧状态,可实现治疗目的【2】。相关研究结果证实,慢性肺源性心脏病使用丹红注射液治疗效果显著。为此,本次研究钟点房分析慢性肺源性心脏病接受常规治疗同时,加用卡托普利及丹红注射液临床。报道如下。

1 资料和方法

1.1一般资料

选取本院2020年1月-2020年12月收治的慢性肺源性心脏病患者90例纳入研究。计算机随机法分组,各45例。对照组,男女患者比例为31:14,年龄53-76(68.86±2.52)岁。观察组,男女患者比例为33:12,年龄54-75(69.04±2.48)岁。……

登录APP查看全文